This inventor holds 8 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Amal Therapeutics Sa, Universitè De Genève, Hopitaux Universitaires De Genève. Active years: 2015-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 6 
2 out of 72 
1 out of 7 Years Active: 2015-2025
Title: Innovator Spotlight: Madiha Derouazi - Pioneering Cancer Treatment
Introduction
Madiha Derouazi, located in Grand-Saconnex, Switzerland, is an accomplished inventor with a notable contribution to the field of cancer treatment. With a portfolio of seven patents, she has been at the forefront of innovative medical therapies, particularly those targeting colorectal cancer. Her work has significant implications for improving the efficacy of cancer treatment options.
Latest Patents
Among her latest innovations, Derouazi has developed a complex comprising a cell-penetrating peptide, an antigen or antigenic epitope, and a TLR (Toll-Like Receptor) peptide agonist for the prevention and treatment of colorectal cancer. This inventive complex offers a novel approach to cancer therapy, presenting potential pharmaceutical compositions and vaccines aimed at combating colorectal cancer effectively.
Additionally, she has created a fusion of a cell-penetrating peptide, a multi-epitope, and a TLR peptide agonist for the treatment of cancer, accentuating her focus on enhancing targeted therapeutic methods. This innovation also emphasizes the potential development of new pharmaceutical compositions and vaccines that could play a crucial role in cancer treatment protocols.
Career Highlights
Madiha Derouazi has made significant strides in her career, having worked with renowned organizations such as Amal Therapeutics SA and the University of Geneva. Her role in these institutions has allowed her to collaborate on groundbreaking research and contribute to advancements in the biomedical field. Derouazi’s dedication to innovation is evident through her extensive research and development efforts.
Collaborations
Throughout her career, Derouazi has collaborated with notable professionals in the industry, including Elodie Belnoue and Paul Walker. These collaborations have enriched her research endeavors and fostered innovative solutions in cancer treatment technology.
Conclusion
Madiha Derouazi stands out as a pioneering inventor whose work is shaping the future of cancer therapies. Her seven patents highlight her commitment to innovation and the critical role she plays in developing effective treatments for colorectal cancer. As the medical field advances, Derouazi’s contributions will undoubtedly continue to impact the world of oncology positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile